Literature DB >> 18398258

Bone markers and bone mineral density in Duchenne muscular dystrophy.

A C Söderpalm1, P Magnusson, A C Ahlander, J Karlsson, A K Kroksmark, M Tulinius, D Swolin-Eide.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18398258

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN： 1108-7161            Impact factor:   2.041


× No keyword cloud information.
  4 in total

1.  Bone is functionally impaired in dystrophic mice but less so than skeletal muscle.

Authors:  Susan A Novotny; Gordon L Warren; Angela S Lin; Robert E Guldberg; Kristen A Baltgalvis; Dawn A Lowe
Journal:  Neuromuscul Disord       Date:  2011-01-21       Impact factor: 4.296

Review 2.  Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.

Authors:  Jennifer M Bell; Michael D Shields; Janet Watters; Alistair Hamilton; Timothy Beringer; Mark Elliott; Rosaline Quinlivan; Sandya Tirupathi; Bronagh Blackwood
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

3.  Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.

Authors:  Christian Isaac; Adam Wright; Arvydas Usas; Hongshuai Li; Ying Tang; Xiaodong Mu; Nicholas Greco; Qing Dong; Nam Vo; James Kang; Bing Wang; Johnny Huard
Journal:  J Orthop Res       Date:  2012-10-23       Impact factor: 3.494

4.  Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.

Authors:  Tero Puolakkainen; Hongqian Ma; Heikki Kainulainen; Arja Pasternack; Timo Rantalainen; Olli Ritvos; Kristiina Heikinheimo; Juha J Hulmi; Riku Kiviranta
Journal:  BMC Musculoskelet Disord       Date:  2017-01-19       Impact factor: 2.362
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.